【礼邦医药-B(09637.HK)盈喜：上半年收入暴涨超7倍，亏损显著收窄，成长潜力备受关注】智通财经APP获悉，8月6日盘后，礼邦医药-B(09637.HK)发布盈利预喜公告，披露截至2026年6月30日止六个月的未经审核财务表现。报告期内，集团预期录得收入约人民币1.03亿元至1.06亿元，较去年同期约人民币1210万元大幅增长约750%至775%;期内亏损预计约人民币1.58亿元至1.78亿元，较去年同期约人民币2.10亿元收窄约15%至25%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.